UK Biotechs Present Novel Technologies at BioTrinity 2017
Biotechnology Rolls on Despite Brexit Uncertainty
Avoiding Costly Errors in Bioassay Development
Developers Have a Range of Options When Optimizing Bioassays for Biologics
Screening Innovations and 3D Cell Culture Assay Developments
Showcased at ELRIG
New Tech Aids Drug Discovery
In Scientific Publishing, Sharing Is Caring
The Saga for Open-Access Research Continues
For full access to this article login to GEN Select now.
Exploiting Post-Translational Modifications
Assessing Strategies to Meet Demand
- By 2010, glycoprotein and antibody drugs are expected to exceed $68 billion in worldwide sales. Meeting the demand for such therapeutics is generating challenges for both production and manufacturing. Chief among these is accurately and reproducibly mimicking natural post-translational modifications. Identifying and characterizing such modifications impact half-life, quality, ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.